Tarsus issues 'call to action' months before FDA decision on eye mite treatment
09 May 2023
Drug Approval
Tarsus Pharmaceuticals has a message for patients who think they may have Demodex blepharitis or irritated eyes caused by tiny mites: “Don’t freak out. Get checked out.”
The new unbranded
campaign
launched on Monday, just a few months before the FDA is expected to make a decision on Tarsus’ treatment, a version of the common veterinary drug lotilaner used to prevent tick and flea infestations in dogs. An approval would mark the first time the drug has been cleared for humans. While Tarsus’
last campaign
, “Look at the Lids,” targeted eyecare professionals, this one aims to educate patients about the symptoms and diagnosis of Demodex blepharitis.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.